A Case Report of Isopropanol Ingestion During the SARS-CoV-2 Pandemic.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 32852316.
- Also identified by DOI 10.1097/ADM.0000000000000728.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with substance use disorder may be particularly vulnerable to withdrawal-related complications during the SARS-CoV-2 (COVID-19) pandemic. Limited availability of alcohol and other substances coupled with decreased accessibility to substance use treatment poses a substantial risk to this population. Isopropanol, the active ingredient in rubbing alcohol, is widely available; thus, it may be used in times of scarcity. We present a case of intentional isopropanol ingestion used as an ethanol surrogate within the setting of the COVID-19 pandemic. Toxic alcohol ingestions are imperative considerations on the differential for the intoxicated patient particularly during resource-limited times.
Medical subject headings
- 2-Propanol
- Alcoholism
- Coronavirus Infections
- Pneumonia, Viral
- Self Medication